| | | | | | | | | | |
|
|
| Dockets Entered
On April 24, 2006
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1990S-0308
|
| Generic Drug Speeches & Policy and Procedure Guides
|
|
|
| 2001N-0464
|
| Vaccine Adverse Event Reporting System
|
|
|
| 2003E-0030
|
| Patent Term Extension Application for FASLODEX No. 4,659,516
|
|
|
| 2004H-0322
|
| Civil Money Penalty Re: Ecumed Health Group, Inc.
|
|
|
| 2005D-0481
|
| Guidance for Industry, Lead in Candy Likely To Be Consumed Frequently by Small Children: Recommended Maximum Level and Enforcement Policy, Availability; and draft supporting document, Supporting Do
|
|
|
|
|
|
| 2005N-0355
|
| Revocation of Status of Specific Products; Group A Streptococcus
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
| 2006N-0029
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Impact of Coupons on Consumer Perceptions of Products in Prescription Drugs in Direct-to-Consumer Prescription Drug Prin
|
|
|
|
| 2006P-0124
|
| Stay any approvals of an Abbreviated New Drug Application (ANDA) for Vancocin Capsules
|
|
|
| 2006V-0171
|
| Laser Light Show
|
|
|
| 1990S-0308
|
| Generic Drug Speeches & Policy and Procedure Guides
|
|
|
| CR 1
|
| Statistical Report - Month of February 2006
|
| Vol #:
|
| 55
|
|
|
| RPT 765
|
| Statistical Report - Month of March 2006
|
| Vol #:
|
| 55
|
|
|
| 2001N-0464
|
| Vaccine Adverse Event Reporting System
|
|
|
| NWL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2003E-0030
|
| Patent Term Extension Application for FASLODEX No. 4,659,516
|
|
|
| NCR 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004H-0322
|
| Civil Money Penalty Re: Ecumed Health Group, Inc.
|
|
|
| BRF 1
|
| GCF-1
|
| Vol #:
|
| 10
|
|
|
| 2005D-0481
|
| Guidance for Industry, Lead in Candy Likely To Be Consumed Frequently by Small Children: Recommended Maximum Level and Enforcement Policy, Availability; and draft supporting document, Supporting Do
|
|
|
|
|
|
| C 10
|
| Centers for Disease Control and Prevention
|
| Vol #:
|
| 1
|
|
|
| 2005N-0355
|
| Revocation of Status of Specific Products; Group A Streptococcus
|
|
|
| NCD 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
| C 6654
|
| S. Caruso
|
| Vol #:
|
| 90
|
|
|
| C 6655
|
| P. Kennedy
|
| Vol #:
|
| 90
|
|
|
| C 6656
|
| L. Newman
|
| Vol #:
|
| 90
|
|
|
| C 6657
|
| R. Eldred
|
| Vol #:
|
| 90
|
|
|
| C 6658
|
| D. Bradley
|
| Vol #:
|
| 90
|
|
|
| C 6659
|
| j. Mosier
|
| Vol #:
|
| 90
|
|